Roman Yelensky

Roman Yelensky, PhD, is Vice President of Clinical Applications at 10x Genomics, where he started and leads the company’s diagnostics R&D group. The team works with leading academic medical centers to investigate applications of single-cell and spatial biology tools in oncology and autoimmune disease. Roman has spent more than 15 years building precision medicine platforms. As employee #6 at Foundation Medicine, he co-led development of the FoundationOne® comprehensive genomic profiling test and established the program that produced the first FDA-approved NGS-based companion diagnostic. He was later employee #1 and Chief Technology Officer at Gritstone bio, where he helped take the personalized immunotherapy company from inception to IPO and Phase 2 clinical trials. Most recently he founded and led Serum Detect, a venture-backed liquid biopsy startup. Roman trained at MIT (PhD), Stanford, and Cornell, has co-authored 75 publications, and holds 22 issued patents.